{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:39:20Z","timestamp":1788910760079,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":167,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030304010","type":"print"},{"value":"9783030304027","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-30402-7_23","type":"book-chapter","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T03:04:26Z","timestamp":1580439866000},"page":"615-646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence"],"prefix":"10.1007","author":[{"given":"Ranjana","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti K.","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Kuhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"23_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. Author.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"23_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10882-017-9573-x","volume":"30","author":"JA Estabillo","year":"2018","unstructured":"Estabillo, J. A., Matson, J. L., & Cervantes, P. E. (2018). Autism symptoms and problem behaviors in children with and without developmental regression. Journal of Developmental and Physical Disabilities, 30, 17\u201326. \nhttps:\/\/doi.org\/10.1007\/s10882-017-9573-x","journal-title":"Journal of Developmental and Physical Disabilities"},{"key":"23_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4137\/CMPed.S38337","volume":"10","author":"RE Frye","year":"2016","unstructured":"Frye, R. E., & Rossignol, D. A. (2016). Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes. Clinical Medicine Insights. Pediatrics, 10, 43\u201356. \nhttps:\/\/doi.org\/10.4137\/CMPed.S38337","journal-title":"Clinical Medicine Insights. Pediatrics"},{"key":"23_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4419-8065-6_5","volume-title":"International handbook of autism and pervasive developmental disorders","author":"SB Helverschou","year":"2011","unstructured":"Helverschou, S. B., Bakken, T. L., & Martinsen, H. (2011). Psychiatric disorders in people with autism spectrum disorders: Phenomenology and recognition. In International handbook of autism and pervasive developmental disorders (pp. 53\u201374). New York: Springer."},{"key":"23_CR5","unstructured":"WHO. (2017). Autism spectrum disorders. Author."},{"issue":"Suppl 10","key":"23_CR6","first-page":"3","volume":"66","author":"E Fombonne","year":"2005","unstructured":"Fombonne, E. (2005). Epidemiology of autistic disorder and other pervasive developmental disorders. The Journal of Clinical Psychiatry, 66(Suppl 10), 3\u20138.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"23_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/emmm.201100157","volume":"3","author":"R Holt","year":"2011","unstructured":"Holt, R., & Monaco, A. P. (2011). Links between genetics and pathophysiology in the autism spectrum disorders. EMBO Molecular Medicine, 3, 438\u2013450. \nhttps:\/\/doi.org\/10.1002\/emmm.201100157","journal-title":"EMBO Molecular Medicine"},{"key":"23_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00129785-200505020-00001","volume":"5","author":"SL Santangelo","year":"2005","unstructured":"Santangelo, S. L., & Tsatsanis, K. (2005). What is known about autism: Genes, brain, and behavior. American Journal of Pharmacogenomics, 5, 71\u201392.","journal-title":"American Journal of Pharmacogenomics"},{"key":"23_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/WCO.0b013e32835ee548","volume":"26","author":"DM Werling","year":"2013","unstructured":"Werling, D. M., & Geschwind, D. H. (2013). Sex differences in autism spectrum disorders. Current Opinion in Neurology, 26, 146\u2013153. \nhttps:\/\/doi.org\/10.1097\/WCO.0b013e32835ee548","journal-title":"Current Opinion in Neurology"},{"key":"23_CR10","doi-asserted-by":"publisher","unstructured":"Ciernia, A. V., Laufer, B. I., Dunaway K. W., et al. (2018). Epigenomic convergence of genetic and immune risk factors in autism brain. bioRxiv 270827. \nhttps:\/\/doi.org\/10.1101\/270827","DOI":"10.1101\/270827"},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2013.12.001","volume":"39","author":"EJH Jones","year":"2014","unstructured":"Jones, E. J. H., Gliga, T., Bedford, R., et al. (2014). Developmental pathways to autism: A review of prospective studies of infants at risk. Neuroscience and Biobehavioral Reviews, 39, 1\u201333. \nhttps:\/\/doi.org\/10.1016\/j.neubiorev.2013.12.001","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"23_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/jhg.2013.49","volume":"58","author":"JM LaSalle","year":"2013","unstructured":"LaSalle, J. M. (2013). Epigenomic strategies at the interface of genetic and environmental risk factors for autism. Journal of Human Genetics, 58, 396\u2013401. \nhttps:\/\/doi.org\/10.1038\/jhg.2013.49","journal-title":"Journal of Human Genetics"},{"key":"23_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13229-017-0121-4","volume":"8","author":"A Modabbernia","year":"2017","unstructured":"Modabbernia, A., Velthorst, E., & Reichenberg, A. (2017). Environmental risk factors for autism: An evidence-based review of systematic reviews and meta-analyses. Molecular Autism, 8, 13. \nhttps:\/\/doi.org\/10.1186\/s13229-017-0121-4","journal-title":"Molecular Autism"},{"key":"23_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.braindev.2012.03.015","volume":"35","author":"A Benvenuto","year":"2013","unstructured":"Benvenuto, A., Battan, B., Porfirio, M. C., & Curatolo, P. (2013). Pharmacotherapy of autism spectrum disorders. Brain & Development, 35, 119\u2013127. \nhttps:\/\/doi.org\/10.1016\/j.braindev.2012.03.015","journal-title":"Brain & Development"},{"key":"23_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/yco.0000000000000132","volume":"28","author":"NJ Young","year":"2015","unstructured":"Young, N. J., & Findling, R. L. (2015). An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Current Opinion in Psychiatry, 28, 91\u2013101. \nhttps:\/\/doi.org\/10.1097\/yco.0000000000000132","journal-title":"Current Opinion in Psychiatry"},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s10578-016-0704-x","volume":"48","author":"H Ichikawa","year":"2017","unstructured":"Ichikawa, H., Mikami, K., Okada, T., et al. (2017). Aripiprazole in the treatment of irritability in children and adolescents with autism spectrum disorder in Japan: A randomized, double-blind, placebo-controlled study. Child Psychiatry and Human Development, 48, 796\u2013806. \nhttps:\/\/doi.org\/10.1007\/s10578-016-0704-x","journal-title":"Child Psychiatry and Human Development"},{"key":"23_CR17","doi-asserted-by":"publisher","first-page":"S1107","DOI":"10.1016\/S0924-977X(17)31922-3","volume":"27","author":"N Maneeton","year":"2017","unstructured":"Maneeton, N., Maneeton, B., Putthisri, S., et al. (2017). Risperidone versus placebo in the treatment of children and adolescents with autism spectrum disorders: A meta-analysis and systematic review. European Neuropsychopharmacology, 27, S1107\u2013S1108. \nhttps:\/\/doi.org\/10.1016\/S0924-977X(17)31922-3","journal-title":"European Neuropsychopharmacology"},{"key":"23_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10803-017-3304-0","volume":"48","author":"T Kerin","year":"2018","unstructured":"Kerin, T., Volk, H., Li, W., et al. (2018). Association between air pollution exposure, cognitive and adaptive function, and ASD severity among children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 48, 137\u2013150. \nhttps:\/\/doi.org\/10.1007\/s10803-017-3304-0","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"23_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/J.BBI.2017.09.010","volume":"67","author":"A Nadeem","year":"2018","unstructured":"Nadeem, A., Ahmad, S. F., Attia, S. M., et al. (2018). Activation of IL-17 receptor leads to increased oxidative inflammation in peripheral monocytes of autistic children. Brain, Behavior, and Immunity, 67, 335\u2013344. \nhttps:\/\/doi.org\/10.1016\/J.BBI.2017.09.010","journal-title":"Brain, Behavior, and Immunity"},{"key":"23_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/mp.2011.165","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol, D. A., & Frye, R. E. (2012). A review of research trends in physiological abnormalities in autism spectrum disorders: Immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Molecular Psychiatry, 17, 389\u2013401. \nhttps:\/\/doi.org\/10.1038\/mp.2011.165","journal-title":"Molecular Psychiatry"},{"key":"23_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fphys.2014.00150","volume":"5","author":"DA Rossignol","year":"2014","unstructured":"Rossignol, D. A., & Frye, R. E. (2014). Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Frontiers in Physiology, 5, 150. \nhttps:\/\/doi.org\/10.3389\/fphys.2014.00150","journal-title":"Frontiers in Physiology"},{"key":"23_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10803-013-1973-x","volume":"44","author":"V Chaidez","year":"2014","unstructured":"Chaidez, V., Hansen, R. L., & Hertz-Picciotto, I. (2014). Gastrointestinal problems in children with autism, developmental delays or typical development. Journal of Autism and Developmental Disorders, 44, 1117\u20131127. \nhttps:\/\/doi.org\/10.1007\/s10803-013-1973-x","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"23_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0022-3476(99)70052-1","volume":"135","author":"K Horvath","year":"1999","unstructured":"Horvath, K., Papadimitriou, J. C., Rabsztyn, A., et al. (1999). Gastrointestinal abnormalities in children with autistic disorder. The Journal of Pediatrics, 135, 559\u2013563.","journal-title":"The Journal of Pediatrics"},{"key":"23_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.biopsych.2016.08.024","volume":"81","author":"HE Vuong","year":"2017","unstructured":"Vuong, H. E., & Hsiao, E. Y. (2017). Emerging roles for the gut microbiome in autism spectrum disorder. Biological Psychiatry, 81, 411\u2013423. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2016.08.024","journal-title":"Biological Psychiatry"},{"issue":"11","key":"23_CR25","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1128\/AEM.70.11.6459-6465.2004","volume":"70","author":"Y Song","year":"2004","unstructured":"Song, Y., Liu, C., & Finegold, S. M. (2004). Real-time PCR quantitation of clostridia in feces of autistic children. Applied and Environmental Microbiology, 70(11), 6459\u20136465.","journal-title":"Applied and Environmental Microbiology"},{"key":"23_CR26","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1086\/341914","volume":"35","author":"SM Finegold","year":"2002","unstructured":"Finegold, S. M., Molitoris, D., Song, Y., et al. (2002). Gastrointestinal microflora studies in late-onset autism. Clinical Infectious Diseases, 35, S6\u2013S16. \nhttps:\/\/doi.org\/10.1086\/341914","journal-title":"Clinical Infectious Diseases"},{"key":"23_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2040-2392-4-42","volume":"4","author":"L Wang","year":"2013","unstructured":"Wang, L., Christophersen, C. T., Sorich, M. J., et al. (2013). Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Molecular Autism, 4, 42. \nhttps:\/\/doi.org\/10.1186\/2040-2392-4-42","journal-title":"Molecular Autism"},{"key":"23_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/J.JCMGH.2016.11.008","volume":"3","author":"RA Luna","year":"2017","unstructured":"Luna, R. A., Oezguen, N., Balderas, M., et al. (2017). Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism Spectrum disorder. Cellular and Molecular Gastroenterology and Hepatology, 3, 218\u2013230. \nhttps:\/\/doi.org\/10.1016\/J.JCMGH.2016.11.008","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"23_CR29","doi-asserted-by":"publisher","unstructured":"Toh, M. C., & Allen-Vercoe, E. (2015). The human gut microbiota with reference to autism spectrum disorder: Considering the whole as more than a sum of its parts. Microbial Ecology in Health and Disease, 26. \nhttps:\/\/doi.org\/10.3402\/mehd.v26.26309","DOI":"10.3402\/mehd.v26.26309"},{"key":"23_CR30","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1021\/jf104380f","volume":"59","author":"L Hask\u00e5","year":"2011","unstructured":"Hask\u00e5, L., Andersson, R., & Nyman, M. (2011). The effect of dietary fiber from wheat processing streams on the formation of carboxylic acids and microbiota in the hindgut of rats. Journal of Agricultural and Food Chemistry, 59, 3406\u20133413. \nhttps:\/\/doi.org\/10.1021\/jf104380f","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"23_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000065416","volume":"46","author":"H Jyonouchi","year":"2002","unstructured":"Jyonouchi, H., Sun, S., & Itokazu, N. (2002). Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology, 46, 76\u201384.","journal-title":"Neuropsychobiology"},{"key":"23_CR32","doi-asserted-by":"publisher","DOI":"10.3402\/mehd.v26.28177","volume":"26","author":"DF Macfabe","year":"2015","unstructured":"Macfabe, D. F. (2015). Enteric short-chain fatty acids: Microbial messengers of metabolism, mitochondria, and mind: Implications in autism spectrum disorders. Microbial Ecology in Health and Disease, 26, 28177. \nhttps:\/\/doi.org\/10.3402\/mehd.v26.28177","journal-title":"Microbial Ecology in Health and Disease"},{"key":"23_CR33","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1007\/s12035-016-0004-2","volume":"54","author":"G Morris","year":"2017","unstructured":"Morris, G., Berk, M., Carvalho, A., et al. (2017). The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease. Molecular Neurobiology, 54, 4432\u20134451. \nhttps:\/\/doi.org\/10.1007\/s12035-016-0004-2","journal-title":"Molecular Neurobiology"},{"key":"23_CR34","unstructured":"Strasser, L. (2016). The effects of propionic acid on locomotor, repetitive and anxiety-related behaviors in female adolescent rats. Western Undergraduate Psychology Journal, 4."},{"key":"23_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/bjc.1993.485","volume":"68","author":"AR Karuri","year":"1993","unstructured":"Karuri, A. R., Dobrowsky, E., & Tannock, I. F. (1993). Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment. British Journal of Cancer, 68, 1080\u20131087.","journal-title":"British Journal of Cancer"},{"key":"23_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molbrainres.2005.09.002","volume":"142","author":"M DeCastro","year":"2005","unstructured":"DeCastro, M., Nankova, B. B., Shah, P., et al. (2005). Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Brain Research. Molecular Brain Research, 142, 28\u201338. \nhttps:\/\/doi.org\/10.1016\/j.molbrainres.2005.09.002","journal-title":"Brain Research. Molecular Brain Research"},{"key":"23_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0197-0186(02)00211-5","volume":"43","author":"C Cannizzaro","year":"2003","unstructured":"Cannizzaro, C., Monastero, R., Vacca, M., & Martire, M. (2003). [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: Involvement of calcium ions. Neurochemistry International, 43, 9\u201317.","journal-title":"Neurochemistry International"},{"key":"23_CR38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/1742-2094-9-74","volume":"9","author":"AK El-Ansary","year":"2012","unstructured":"El-Ansary, A. K., Ben Bacha, A., & Kotb, M. (2012). Etiology of autistic features: The persisting neurotoxic effects of propionic acid. Journal of Neuroinflammation, 9, 661. \nhttps:\/\/doi.org\/10.1186\/1742-2094-9-74","journal-title":"Journal of Neuroinflammation"},{"key":"23_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.brainresbull.2006.10.006","volume":"71","author":"N Sziray","year":"2007","unstructured":"Sziray, N., Leveleki, C., Levay, G., et al. (2007). Mechanisms underlying the long-term behavioral effects of traumatic experience in rats: The role of serotonin\/noradrenaline balance and NMDA receptors. Brain Research Bulletin, 71, 376\u2013385. \nhttps:\/\/doi.org\/10.1016\/j.brainresbull.2006.10.006","journal-title":"Brain Research Bulletin"},{"key":"23_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192925","volume":"13","author":"J Choi","year":"2018","unstructured":"Choi, J., Lee, S., Won, J., et al. (2018). Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model. PLoS One, 13, e0192925. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0192925","journal-title":"PLoS One"},{"key":"23_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1023\/B:BOLI.0000037353.13085.e2","volume":"27","author":"M Wajner","year":"2004","unstructured":"Wajner, M., Latini, A., Wyse, A. T. S., & Dutra-Filho, C. S. (2004). The role of oxidative damage in the neuropathology of organic acidurias: Insights from animal studies. Journal of Inherited Metabolic Disease, 27, 427\u2013448. \nhttps:\/\/doi.org\/10.1023\/B:BOLI.0000037353.13085.e2","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"23_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12979-016-0070-3","volume":"13","author":"S Davinelli","year":"2016","unstructured":"Davinelli, S., Maes, M., Corbi, G., et al. (2016). Dietary phytochemicals and neuro-inflammaging: From mechanistic insights to translational challenges. Immunity & Ageing, 13, 16. \nhttps:\/\/doi.org\/10.1186\/s12979-016-0070-3","journal-title":"Immunity & Ageing"},{"key":"23_CR43","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1124\/pr.113.007757","volume":"66","author":"J Lee","year":"2014","unstructured":"Lee, J., Jo, D.-G., Park, D., et al. (2014). Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: Focus on the nervous system. Pharmacological Reviews, 66, 815\u2013868. \nhttps:\/\/doi.org\/10.1124\/pr.113.007757","journal-title":"Pharmacological Reviews"},{"key":"23_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","volume":"79","author":"M Sandberg","year":"2014","unstructured":"Sandberg, M., Patil, J., D\u2019Angelo, B., et al. (2014). NRF2-regulation in brain health and disease: Implication of cerebral inflammation. Neuropharmacology, 79, 298\u2013306. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.004","journal-title":"Neuropharmacology"},{"key":"23_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0166-2236(96)01035-1","volume":"20","author":"LA O\u2019Neill","year":"1997","unstructured":"O\u2019Neill, L. A., & Kaltschmidt, C. (1997). NF-kappa B: A crucial transcription factor for glial and neuronal cell function. Trends in Neurosciences, 20, 252\u2013258.","journal-title":"Trends in Neurosciences"},{"key":"23_CR46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12035-013-8555-y","volume":"49","author":"WM Snow","year":"2014","unstructured":"Snow, W. M., Stoesz, B. M., Kelly, D. M., & Albensi, B. C. (2014). Roles for NF-\u03baB and gene targets of NF-\u03baB in synaptic plasticity, memory, and navigation. Molecular Neurobiology, 49, 757\u2013770. \nhttps:\/\/doi.org\/10.1007\/s12035-013-8555-y","journal-title":"Molecular Neurobiology"},{"issue":"13","key":"23_CR47","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1021\/acs.jafc.7b04975","volume":"66","author":"H Chen","year":"2018","unstructured":"Chen, H., & Liu, R. H. (2018). Potential mechanisms of action of dietary phytochemicals for cancer prevention by targeting cellular signaling transduction pathways. Journal of Agricultural and Food Chemistry, 66(13), 3260\u20133276. \nhttps:\/\/doi.org\/10.1021\/acs.jafc.7b04975","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"23_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1460-9568.2004.03824.x","volume":"21","author":"S Duvarci","year":"2005","unstructured":"Duvarci, S., Nader, K., & LeDoux, J. E. (2005). Activation of extracellular signal-regulated kinase- mitogen-activated protein kinase cascade in the amygdala is required for memory reconsolidation of auditory fear conditioning. The European Journal of Neuroscience, 21, 283\u2013289. \nhttps:\/\/doi.org\/10.1111\/j.1460-9568.2004.03824.x","journal-title":"The European Journal of Neuroscience"},{"key":"23_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073875","volume":"8","author":"YS Hori","year":"2013","unstructured":"Hori, Y. S., Kuno, A., Hosoda, R., & Horio, Y. (2013). Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One, 8, e73875. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0073875","journal-title":"PLoS One"},{"key":"23_CR50","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1074\/jbc.M110.163667","volume":"286","author":"S Xiong","year":"2011","unstructured":"Xiong, S., Salazar, G., Patrushev, N., & Alexander, R. W. (2011). FoxO1 mediates an autofeedback loop regulating SIRT1 expression. The Journal of Biological Chemistry, 286, 5289\u20135299. \nhttps:\/\/doi.org\/10.1074\/jbc.M110.163667","journal-title":"The Journal of Biological Chemistry"},{"key":"23_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0973-7847.99898","volume":"6","author":"GP Kumar","year":"2012","unstructured":"Kumar, G. P., & Khanum, F. (2012). Neuroprotective potential of phytochemicals. Pharmacognosy Reviews, 6, 81\u201390. \nhttps:\/\/doi.org\/10.4103\/0973-7847.99898","journal-title":"Pharmacognosy Reviews"},{"key":"23_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/608654","volume":"2013","author":"LR Frick","year":"2013","unstructured":"Frick, L. R., Williams, K., & Pittenger, C. (2013). Microglial dysregulation in psychiatric disease. Clinical & Developmental Immunology, 2013, 608654. \nhttps:\/\/doi.org\/10.1155\/2013\/608654","journal-title":"Clinical & Developmental Immunology"},{"key":"23_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas, D. L., Nascimbene, C., Krishnan, C., et al. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67\u201381. \nhttps:\/\/doi.org\/10.1002\/ana.20315","journal-title":"Annals of Neurology"},{"key":"23_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5772\/22318","volume":"76","author":"G Bjorkland","year":"2016","unstructured":"Bjorkland, G., Saad, K., Chirumbolo, S., et al. (2016). Immune dysfunction and neuroinflammation in autism spectrum disorder. Acta Neurobiologiae Experimentalis, 76, 257\u2013268. \nhttps:\/\/doi.org\/10.5772\/22318","journal-title":"Acta Neurobiologiae Experimentalis"},{"key":"23_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000048665","volume":"45","author":"J Croonenberghs","year":"2002","unstructured":"Croonenberghs, J., Bosmans, E., Deboutte, D., et al. (2002). Activation of the inflammatory response system in autism. Neuropsychobiology, 45, 1\u20136.","journal-title":"Neuropsychobiology"},{"key":"23_CR56","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.biopsych.2012.05.004","volume":"72","author":"CE Onore","year":"2012","unstructured":"Onore, C. E., Nordahl, C. W., Young, G. S., et al. (2012). Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder. Biological Psychiatry, 72, 1020\u20131025. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2012.05.004","journal-title":"Biological Psychiatry"},{"key":"23_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.pediatrneurol.2007.01.012","volume":"36","author":"MG Chez","year":"2007","unstructured":"Chez, M. G., Dowling, T., Patel, P. B., et al. (2007). Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatric Neurology, 36, 361\u2013365. \nhttps:\/\/doi.org\/10.1016\/j.pediatrneurol.2007.01.012","journal-title":"Pediatric Neurology"},{"key":"23_CR58","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.biopsych.2005.07.004","volume":"59","author":"AM Connolly","year":"2006","unstructured":"Connolly, A. M., Chez, M., Streif, E. M., et al. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biological Psychiatry, 59, 354\u2013363. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2005.07.004","journal-title":"Biological Psychiatry"},{"issue":"3","key":"23_CR59","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1124\/jpet.116.234476","volume":"358","author":"Y Nakagawa","year":"2016","unstructured":"Nakagawa, Y., & Chiba, K. (2016). Minireviews involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia. Journal of Pharmacology and Experimental Therapeutics, 358(3), 504\u2013515.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"23_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2049-9256-1-16","volume":"1","author":"MW Abdallah","year":"2013","unstructured":"Abdallah, M. W., & Michel, T. M. (2013). Matrix metalloproteinases in autism spectrum disorders. Journal of Molecular Psychiatry, 1, 16. \nhttps:\/\/doi.org\/10.1186\/2049-9256-1-16","journal-title":"Journal of Molecular Psychiatry"},{"key":"23_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2015.00121","volume":"6","author":"C Gottfried","year":"2015","unstructured":"Gottfried, C., & Savino, W. (2015). The impact of neuroimmune alterations in autism spectrum disorder. Frontiers in Psychiatry, 6, 1\u201316. \nhttps:\/\/doi.org\/10.3389\/fpsyt.2015.00121","journal-title":"Frontiers in Psychiatry"},{"key":"23_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ntt.2012.07.006.Cytokine","volume":"36","author":"PE Goines","year":"2013","unstructured":"Goines, P. E., & Ashwood, P. (2013). Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment. Neurotoxicology and Teratology, 36, 67\u201381. \nhttps:\/\/doi.org\/10.1016\/j.ntt.2012.07.006.Cytokine","journal-title":"Neurotoxicology and Teratology"},{"key":"23_CR63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12264-017-0103-8","volume":"33","author":"A Masi","year":"2017","unstructured":"Masi, A., Glozier, N., Dale, R., & Guastella, A. J. (2017). The immune system, cytokines, and biomarkers in autism spectrum disorder. Neuroscience Bulletin, 33, 194\u2013204. \nhttps:\/\/doi.org\/10.1007\/s12264-017-0103-8","journal-title":"Neuroscience Bulletin"},{"key":"23_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"A Chauhan","year":"2006","unstructured":"Chauhan, A., & Chauhan, V. (2006). Oxidative stress in autism. Pathophysiology, 13, 171\u2013181. \nhttps:\/\/doi.org\/10.1016\/j.pathophys.2006.05.007","journal-title":"Pathophysiology"},{"key":"23_CR65","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.lfs.2004.04.038","volume":"75","author":"A Chauhan","year":"2004","unstructured":"Chauhan, A., Chauhan, V., Brown, W. T., & Cohen, I. (2004). Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sciences, 75, 2539\u20132549. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2004.04.038","journal-title":"Life Sciences"},{"key":"23_CR66","first-page":"193","volume":"8","author":"NA Meguid","year":"2016","unstructured":"Meguid, N. A., Azab, S. N., Saber, A. S., et al. (2016). Impact of oxidative stress on autism spectrum disorder behaviors in children with autism. International Journal of Pharmaceutical and Clinical Research, 8, 193\u2013197.","journal-title":"International Journal of Pharmaceutical and Clinical Research"},{"key":"23_CR67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.9734\/BJMMR\/2013\/2335","volume":"3","author":"ME Gonz\u00e1lez-fraguela","year":"2013","unstructured":"Gonz\u00e1lez-fraguela, M. E., Hung, M. D., Vera, H., et al. (2013). Oxidative stress markers in children with autism spectrum disorders. British Journal of Medicine and Medical Research, 3, 307\u2013317.","journal-title":"British Journal of Medicine and Medical Research"},{"key":"23_CR68","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1038\/tp.2015.29","volume":"5","author":"S Rose","year":"2015","unstructured":"Rose, S., Frye, R. E., Slattery, J., et al. (2015). Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Translational Psychiatry, 5, e526. \nhttps:\/\/doi.org\/10.1038\/tp.2015.29","journal-title":"Translational Psychiatry"},{"key":"23_CR69","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/mp.2010.136","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol, D. A., & Frye, R. E. (2012). Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis. Molecular Psychiatry, 17, 290\u2013314. \nhttps:\/\/doi.org\/10.1038\/mp.2010.136","journal-title":"Molecular Psychiatry"},{"key":"23_CR70","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/brain\/awg170","volume":"126","author":"D Skladal","year":"2003","unstructured":"Skladal, D., Halliday, J., & Thorburn, D. R. (2003). Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain, 126, 1905\u20131912.","journal-title":"Brain"},{"key":"23_CR71","doi-asserted-by":"publisher","unstructured":"Palmieri, L., & Persico, A. M. (1797). Mitochondrial dysfunction in autism spectrum disorders: Cause or effect? Biochimica et Biophysica Acta, 1130\u20131137. \nhttps:\/\/doi.org\/10.1016\/j.bbabio.2010.04.018","DOI":"10.1016\/j.bbabio.2010.04.018"},{"key":"23_CR72","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s12311-012-0355-9","volume":"11","author":"CD Blaha","year":"2013","unstructured":"Blaha, C. D., Blatt, G. J., Chauhan, A., et al. (2013). Consensus paper: Pathological role of the cerebellum in autism. Cerebellum, 11, 777\u2013807. \nhttps:\/\/doi.org\/10.1007\/s12311-012-0355-9","journal-title":"Cerebellum"},{"key":"23_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/618127","volume":"2011","author":"F Geraci","year":"2011","unstructured":"Geraci, F., Turturici, G., & Sconzo, G. (2011). Hsp70 and its molecular role in nervous system diseases. Biochemistry Research International, 2011, 618127. \nhttps:\/\/doi.org\/10.1155\/2011\/618127","journal-title":"Biochemistry Research International"},{"key":"23_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1742-2094-10-42","volume":"10","author":"AM Aldbass","year":"2013","unstructured":"Aldbass, A. M., Bhat, R. S., & El-Ansary, A. (2013). Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats. Journal of Neuroinflammation, 10, 42. \nhttps:\/\/doi.org\/10.1186\/1742-2094-10-42","journal-title":"Journal of Neuroinflammation"},{"key":"23_CR75","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2006.07.025","volume":"176","author":"DF MacFabe","year":"2007","unstructured":"MacFabe, D. F., Cain, D. P., Rodriguez-Capote, K., et al. (2007). Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behavioural Brain Research, 176, 149\u2013169. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2006.07.025","journal-title":"Behavioural Brain Research"},{"key":"23_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbr.2008.12.023","volume":"200","author":"SR Shultz","year":"2009","unstructured":"Shultz, S. R., Macfabe, D. F., Martin, S., et al. (2009). Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: Further development of a rodent model of autism. Behavioural Brain Research, 200, 33\u201341. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2008.12.023","journal-title":"Behavioural Brain Research"},{"key":"23_CR77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3844\/ajbbsp.2008.146.166","volume":"4","author":"DF MacFabe","year":"2008","unstructured":"MacFabe, D. F., Rodr\u00edguez-Capote, K., Hoffman, J. E., et al. (2008). A novel rodent model of autism: Intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. American Journal of Biochemistry and Biotechnology, 4, 146\u2013166. \nhttps:\/\/doi.org\/10.3844\/ajbbsp.2008.146.166","journal-title":"American Journal of Biochemistry and Biotechnology"},{"key":"23_CR78","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1038\/tp.2012.143","volume":"3","author":"RE Frye","year":"2013","unstructured":"Frye, R. E., Melnyk, S., & Macfabe, D. F. (2013). Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Translational Psychiatry, 3, e220. \nhttps:\/\/doi.org\/10.1038\/tp.2012.143","journal-title":"Translational Psychiatry"},{"key":"23_CR79","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1038\/tp.2016.189","volume":"6","author":"RE Frye","year":"2016","unstructured":"Frye, R. E., Rose, S., Chacko, J., et al. (2016). Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines. Translational Psychiatry, 6, e927. \nhttps:\/\/doi.org\/10.1038\/tp.2016.189","journal-title":"Translational Psychiatry"},{"key":"23_CR80","doi-asserted-by":"publisher","DOI":"10.3402\/mehd.v23i0.19260","volume":"23","author":"DF Macfabe","year":"2012","unstructured":"Macfabe, D. F. (2012). Short-chain fatty acid fermentation products of the gut microbiome: Implications in autism spectrum disorders. Microbial Ecology in Health and Disease, 23, 19260. \nhttps:\/\/doi.org\/10.3402\/mehd.v23i0.19260","journal-title":"Microbial Ecology in Health and Disease"},{"key":"23_CR81","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jbt","volume":"28","author":"H Ramamoorthy","year":"2014","unstructured":"Ramamoorthy, H., Abraham, P., & Isaac, B. (2014). Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity. Journal of Biochemical and Molecular Toxicology, 28, 246\u2013255. \nhttps:\/\/doi.org\/10.1002\/jbt","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"23_CR82","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.3390\/nu6093777","volume":"6","author":"AL Stefanson","year":"2014","unstructured":"Stefanson, A. L., & Bakovic, M. (2014). Dietary regulation of Keap1\/Nrf2\/ARE pathway: Focus on plant-derived compounds and trace minerals. Nutrients, 6, 3777\u20133801. \nhttps:\/\/doi.org\/10.3390\/nu6093777","journal-title":"Nutrients"},{"key":"23_CR83","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn, J. D., Ponsford, A. H., & Sanderson, C. M. (2015). Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochemical Society Transactions, 43, 621\u2013626. \nhttps:\/\/doi.org\/10.1042\/BST20150014","journal-title":"Biochemical Society Transactions"},{"key":"23_CR84","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","volume":"23","author":"M Yu","year":"2011","unstructured":"Yu, M., Li, H., Liu, Q., et al. (2011). Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cellular Signalling, 23, 883\u2013892. \nhttps:\/\/doi.org\/10.1016\/j.cellsig.2011.01.014","journal-title":"Cellular Signalling"},{"key":"23_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/801418","volume":"2013","author":"S Gonz\u00e1lez-Reyes","year":"2013","unstructured":"Gonz\u00e1lez-Reyes, S., Guzm\u00e1n-Beltr\u00e1n, S., Medina-Campos, O. N., & Pedraza-Chaverri, J. (2013). Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats. Oxidative Medicine and Cellular Longevity, 2013, 801418. \nhttps:\/\/doi.org\/10.1155\/2013\/801418","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"23_CR86","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.brainres.2009.05.009","volume":"1282","author":"C Yang","year":"2009","unstructured":"Yang, C., Zhang, X., Fan, H., & Liu, Y. (2009). Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Research, 1282, 133\u2013141. \nhttps:\/\/doi.org\/10.1016\/j.brainres.2009.05.009","journal-title":"Brain Research"},{"key":"23_CR87","doi-asserted-by":"publisher","first-page":"10420","DOI":"10.1016\/j.jbtep.2015.11.003","volume":"8","author":"L Cheng","year":"2015","unstructured":"Cheng, L., Jin, Z., Zhao, R., et al. (2015). Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: Role of Nrf2\/ARE pathway. International Journal of Clinical and Experimental Medicine, 8, 10420\u201310428. \nhttps:\/\/doi.org\/10.1016\/j.jbtep.2015.11.003","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"23_CR88","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.11.026","volume":"79","author":"H Lou","year":"2014","unstructured":"Lou, H., Jing, X., Wei, X., et al. (2014). Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2\/ARE signaling pathway. Neuropharmacology, 79, 380\u2013388. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.026","journal-title":"Neuropharmacology"},{"key":"23_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/J.TIFS.2017.02.002","volume":"69","author":"AT Dinkova-Kostova","year":"2017","unstructured":"Dinkova-Kostova, A. T., Fahey, J. W., Kostov, R. V., & Kensler, T. W. (2017). KEAP1 and done? Targeting the NRF2 pathway with sulforaphane. Trends in Food Science and Technology, 69, 257\u2013269. \nhttps:\/\/doi.org\/10.1016\/J.TIFS.2017.02.002","journal-title":"Trends in Food Science and Technology"},{"key":"23_CR90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.vph.2016.07.004","volume":"85","author":"PM Holloway","year":"2016","unstructured":"Holloway, P. M., Gillespie, S., Becker, F., et al. (2016). Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways. Vascular Pharmacology, 85, 29\u201338. \nhttps:\/\/doi.org\/10.1016\/j.vph.2016.07.004","journal-title":"Vascular Pharmacology"},{"key":"23_CR91","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bcp.2008.07.036","volume":"76","author":"W Lin","year":"2008","unstructured":"Lin, W., Wu, R. T., Wu, T., et al. (2008). Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochemical Pharmacology, 76, 967\u2013973. \nhttps:\/\/doi.org\/10.1016\/j.bcp.2008.07.036","journal-title":"Biochemical Pharmacology"},{"key":"23_CR92","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/carcin\/19.1.81","volume":"19","author":"JM Kim","year":"1998","unstructured":"Kim, J. M., Araki, S., Kim, D. J., et al. (1998). Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis, 19, 81\u201385.","journal-title":"Carcinogenesis"},{"key":"23_CR93","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1440-1681.2006.04468.x","volume":"33","author":"S Sharma","year":"2006","unstructured":"Sharma, S., Kulkarni, S. K., & Chopra, K. (2006). Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clinical and Experimental Pharmacology & Physiology, 33, 940\u2013945. \nhttps:\/\/doi.org\/10.1111\/j.1440-1681.2006.04468.x","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"23_CR94","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.2042-7158.1973.tb09131.x","volume":"25","author":"RC Srimal","year":"1973","unstructured":"Srimal, R. C., & Dhawan, B. N. (1973). Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. The Journal of Pharmacy and Pharmacology, 25, 447\u2013452.","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"23_CR95","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-0-387-46401-5_8","volume-title":"The molecular targets and therapeutic uses of Curcumin in health and disease","author":"GM Cole","year":"2007","unstructured":"Cole, G. M., Teter, B., & Frautschy, S. A. (2007). Neuroprotective effects of curcumin. In The molecular targets and therapeutic uses of Curcumin in health and disease (pp. 197\u2013212). Boston: Springer."},{"key":"23_CR96","doi-asserted-by":"publisher","first-page":"20864","DOI":"10.3390\/molecules191220864","volume":"19","author":"Y Tizabi","year":"2014","unstructured":"Tizabi, Y., Hurley, L., Qualls, Z., & Akinfiresoye, L. (2014). Relevance of the anti-inflammatory properties of Curcumin in neurodegenerative diseases and depression. Molecules, 19, 20864\u201320879. \nhttps:\/\/doi.org\/10.3390\/molecules191220864","journal-title":"Molecules"},{"key":"23_CR97","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/eye.2013.315","volume":"28","author":"R Motterlini","year":"2000","unstructured":"Motterlini, R., & Foresti, R. (2000). BR and GC. Fast Track Paper., 28, 1303\u20131312. \nhttps:\/\/doi.org\/10.1038\/eye.2013.315","journal-title":"Fast Track Paper."},{"key":"23_CR98","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1742-2094-8-125","volume":"8","author":"M Karlstetter","year":"2011","unstructured":"Karlstetter, M., Lippe, E., Walczak, Y., et al. (2011). Curcumin is a potent modulator of microglial gene expression and migration. Journal of Neuroinflammation, 8, 125. \nhttps:\/\/doi.org\/10.1186\/1742-2094-8-125","journal-title":"Journal of Neuroinflammation"},{"key":"23_CR99","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2013.12.016","volume":"253","author":"MA Tegenge","year":"2014","unstructured":"Tegenge, M. A., Rajbhandari, L., Shrestha, S., et al. (2014). Curcumin protects axons from degeneration in the setting of local neuroinflammation. Experimental Neurology, 253, 102\u2013110. \nhttps:\/\/doi.org\/10.1016\/j.expneurol.2013.12.016","journal-title":"Experimental Neurology"},{"key":"23_CR100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbr.2017.08.014","volume":"335","author":"TB Bassani","year":"2017","unstructured":"Bassani, T. B., Turnes, J. M., Moura, E. L. R., et al. (2017). Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer\u2019s type. Behavioural Brain Research, 335, 41\u201354. \nhttps:\/\/doi.org\/10.1016\/j.bbr.2017.08.014","journal-title":"Behavioural Brain Research"},{"key":"23_CR101","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1021\/nn405077y","volume":"8","author":"SK Tiwari","year":"2014","unstructured":"Tiwari, S. K., Agarwal, S., Seth, B., et al. (2014). Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt\/\u03b2-catenin pathway. ACS Nano, 8, 76\u2013103. \nhttps:\/\/doi.org\/10.1021\/nn405077y","journal-title":"ACS Nano"},{"key":"23_CR102","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1570159X11311040002","volume":"11","author":"W-H Lee","year":"2013","unstructured":"Lee, W.-H., Loo, C.-Y., Bebawy, M., et al. (2013). Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Current Neuropharmacology, 11, 338\u2013378. \nhttps:\/\/doi.org\/10.2174\/1570159X11311040002","journal-title":"Current Neuropharmacology"},{"key":"23_CR103","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/bph.12131","volume":"169","author":"BB Aggarwal","year":"2013","unstructured":"Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013). Curcumin: An orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British Journal of Pharmacology, 169, 1672\u20131692. \nhttps:\/\/doi.org\/10.1111\/bph.12131","journal-title":"British Journal of Pharmacology"},{"key":"23_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2007\/89369","volume":"2007","author":"A Jacob","year":"2007","unstructured":"Jacob, A., Wu, R., Zhou, M., & Wang, P. (2007). Mechanism of the anti-inflammatory effect of Curcumin: PPAR- \u03b3 activation. PPAR Research, 2007, 1\u20135. \nhttps:\/\/doi.org\/10.1155\/2007\/89369","journal-title":"PPAR Research"},{"key":"23_CR105","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.intimp.2007.08.018","volume":"7","author":"K Saja","year":"2007","unstructured":"Saja, K., Babu, M. S., Karunagaran, D., & Sudhakaran, P. R. (2007). Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. International Immunopharmacology, 7, 1659\u20131667. \nhttps:\/\/doi.org\/10.1016\/j.intimp.2007.08.018","journal-title":"International Immunopharmacology"},{"key":"23_CR106","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3892\/etm.2014.1647","volume":"7","author":"Y Zhong","year":"2014","unstructured":"Zhong, Y., Yu, W., Feng, J., et al. (2014). Curcumin suppresses tumor necrosis factor-\u03b1-induced matrix metalloproteinase-2 expression and activity in rat vascular smooth muscle cells via the NF-\u03baB pathway. Experimental and Therapeutic Medicine, 7, 1653\u20131658. \nhttps:\/\/doi.org\/10.3892\/etm.2014.1647","journal-title":"Experimental and Therapeutic Medicine"},{"key":"23_CR107","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/(SICI)1099-1573(199911)13:7<571::AID-PTR494>3.0.CO;2-7","volume":"13","author":"V Rajakrishnan","year":"1999","unstructured":"Rajakrishnan, V., Viswanathan, P., Rajasekharan, K. N., & Menon, V. P. (1999). Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytotherapy Research, 13, 571\u2013574.","journal-title":"Phytotherapy Research"},{"key":"23_CR108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2015.09.012","volume":"141","author":"R Bhandari","year":"2015","unstructured":"Bhandari, R., & Kuhad, A. (2015). Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sciences, 141, 156\u2013169. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2015.09.012","journal-title":"Life Sciences"},{"key":"23_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1763-7","volume":"17","author":"M Al-Askar","year":"2017","unstructured":"Al-Askar, M., Bhat, R. S., Selim, M., et al. (2017). Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism. BMC Complementary and Alternative Medicine, 17, 1\u201311. \nhttps:\/\/doi.org\/10.1186\/s12906-017-1763-7","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"23_CR110","unstructured":"Shu-juan, C., Zhi-mei, J., Shi-ling, Z., Qi-feng, S., & Lan-min, G. W. P. (2012). Effect of Curcumin on behavior of autism rats and the expression of brain derived neurotrophic factor. Journal of Applied Clinical Pediatrics."},{"key":"23_CR111","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0024-3205(99)00410-5","volume":"66","author":"L Fr\u00e9mont","year":"2000","unstructured":"Fr\u00e9mont, L. (2000). Biological effects of resveratrol. Life Sciences, 66, 663\u2013673. \nhttps:\/\/doi.org\/10.1016\/S0024-3205(99)00410-5","journal-title":"Life Sciences"},{"key":"23_CR112","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2337\/db09-1732","volume":"59","author":"MD Fullerton","year":"2010","unstructured":"Fullerton, M. D., & Steinberg, G. R. (2010). SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes, 59, 551\u2013553. \nhttps:\/\/doi.org\/10.2337\/db09-1732","journal-title":"Diabetes"},{"key":"23_CR113","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-6-26","volume":"6","author":"L Wendeburg","year":"2009","unstructured":"Wendeburg, L., de Oliveira, A. C. P., Bhatia, H. S., et al. (2009). Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells. Journal of Neuroinflammation, 6, 26. \nhttps:\/\/doi.org\/10.1186\/1742-2094-6-26","journal-title":"Journal of Neuroinflammation"},{"key":"23_CR114","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.freeradbiomed.2008.12.016","volume":"46","author":"YT Wong","year":"2009","unstructured":"Wong, Y. T., Gruber, J., Jenner, A. M., et al. (2009). Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: Protection by chronic oral intake of resveratrol. Free Radical Biology & Medicine, 46, 799\u2013809. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.12.016","journal-title":"Free Radical Biology & Medicine"},{"key":"23_CR115","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1089\/jmf.2006.143","volume":"10","author":"YA Kim","year":"2007","unstructured":"Kim, Y. A., Kim, G.-Y., Park, K.-Y., & Choi, Y. H. (2007). Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia. Journal of Medicinal Food, 10, 218\u2013224. \nhttps:\/\/doi.org\/10.1089\/jmf.2006.143","journal-title":"Journal of Medicinal Food"},{"key":"23_CR116","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1016\/j.lfs.2005.10.030","volume":"78","author":"D Gao","year":"2006","unstructured":"Gao, D., Zhang, X., Jiang, X., et al. (2006). Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sciences, 78, 2564\u20132570. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2005.10.030","journal-title":"Life Sciences"},{"key":"23_CR117","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neulet.2008.12.045","volume":"451","author":"G Cheng","year":"2009","unstructured":"Cheng, G., Zhang, X., Gao, D., et al. (2009). Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neuroscience Letters, 451, 105\u2013108. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2008.12.045","journal-title":"Neuroscience Letters"},{"key":"23_CR118","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2014.09.039","volume":"583","author":"V Bambini-Junior","year":"2014","unstructured":"Bambini-Junior, V., Zanatta, G., Della Flora Nunes, G., et al. (2014). Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neuroscience Letters, 583, 176\u2013181. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2014.09.039","journal-title":"Neuroscience Letters"},{"key":"23_CR119","doi-asserted-by":"publisher","unstructured":"Moussa, C., Hebron, M., Huang, X., et al. (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. Journal of Neuroinflammation, 14(1). \nhttps:\/\/doi.org\/10.1186\/s12974-016-0779-0","DOI":"10.1186\/s12974-016-0779-0"},{"key":"23_CR120","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jfma.2015.05.010","volume":"115","author":"RY Tsai","year":"2016","unstructured":"Tsai, R. Y., Wang, J. C., Chou, K. Y., et al. (2016). Resveratrol reverses morphine-induced neuroinflammation in morphine-tolerant rats by reversal HDAC1 expression. Journal of the Formosan Medical Association, 115, 445\u2013454. \nhttps:\/\/doi.org\/10.1016\/j.jfma.2015.05.010","journal-title":"Journal of the Formosan Medical Association"},{"key":"23_CR121","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.3390\/molecules19067327","volume":"19","author":"AE McCalley","year":"2014","unstructured":"McCalley, A. E., Kaja, S., Payne, A. J., & Koulen, P. (2014). Resveratrol and calcium signaling: Molecular mechanisms and clinical relevance. Molecules, 19, 7327\u20137340. \nhttps:\/\/doi.org\/10.3390\/molecules19067327","journal-title":"Molecules"},{"key":"23_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnsyn.2018.00009","volume":"10","author":"M Fontes-Dutra","year":"2018","unstructured":"Fontes-Dutra, M., Santos-Terra, J., Deckmann, I., et al. (2018). Resveratrol prevents cellular and behavioral sensory alterations in the animal model of autism induced by valproic acid. Frontiers in Synaptic Neuroscience, 10, 1\u201312. \nhttps:\/\/doi.org\/10.3389\/fnsyn.2018.00009","journal-title":"Frontiers in Synaptic Neuroscience"},{"key":"23_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-018-0225-5","volume":"9","author":"W Xie","year":"2018","unstructured":"Xie, W., Ge, X., Li, L., et al. (2018). Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ER\u03b2 activation. Molecular Autism, 9, 1\u201313. \nhttps:\/\/doi.org\/10.1186\/s13229-018-0225-5","journal-title":"Molecular Autism"},{"key":"23_CR124","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuint.2016.12.012","volume":"103","author":"R Bhandari","year":"2017","unstructured":"Bhandari, R., & Kuhad, A. (2017). Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders. Neurochemistry International, 103, 8\u201323. \nhttps:\/\/doi.org\/10.1016\/j.neuint.2016.12.012","journal-title":"Neurochemistry International"},{"key":"23_CR125","doi-asserted-by":"publisher","first-page":"G1148","DOI":"10.1152\/ajpgi.2000.279.6.G1148","volume":"279","author":"C Felgines","year":"2000","unstructured":"Felgines, C., Texier, O., Morand, C., et al. (2000). Bioavailability of the flavanone naringenin and its glycosides in rats. American Journal of Physiology. Gastrointestinal and Liver Physiology, 279, G1148\u2013G1154.","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"23_CR126","doi-asserted-by":"publisher","first-page":"9667","DOI":"10.1021\/jf302791k","volume":"60","author":"A Vallverdu","year":"2012","unstructured":"Vallverdu, A., Odriozola-serrano, I., Oms-oliu, G., et al. (2012). Changes in the polyphenol profile of tomato juices processed by pulsed electric fields. Journal of Agricultural and Food Chemistry, 60, 9667\u20139672.","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"23_CR127","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2125.1993.tb04162.x","volume":"35","author":"U Fuhr","year":"1993","unstructured":"Fuhr, U., Klittich, K., & Staib, A. H. (1993). Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. British Journal of Clinical Pharmacology, 35, 431\u2013436. \nhttps:\/\/doi.org\/10.1111\/j.1365-2125.1993.tb04162.x","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"8","key":"23_CR128","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1021\/acs.jafc.5b05067","volume":"64","author":"S Kumar","year":"2016","unstructured":"Kumar, S., & Tiku, A. B. (2016). Biochemical and molecular mechanisms of radioprotective effects of Naringenin, a phytochemical from citrus fruits. Journal of Agricultural and Food Chemistry, 64(8), 1676\u20131685. \nhttps:\/\/doi.org\/10.1021\/acs.jafc.5b05067","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"23_CR129","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/hep.22197","volume":"47","author":"Y Nahmias","year":"2008","unstructured":"Nahmias, Y., Goldwasser, J., Casali, M., et al. (2008). Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology, 47, 1437\u20131445. \nhttps:\/\/doi.org\/10.1002\/hep.22197","journal-title":"Hepatology"},{"key":"23_CR130","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pnpbp.2013.10.002","volume":"48","author":"L-T Yi","year":"2014","unstructured":"Yi, L.-T., Liu, B.-B., Li, J., et al. (2014). BDNF signaling is necessary for the antidepressant-like effect of naringenin. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 48, 135\u2013141. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2013.10.002","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"23_CR131","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0163-7258(01)00137-1","volume":"90","author":"DF Birt","year":"2001","unstructured":"Birt, D. F., Hendrich, S., & Wang, W. (2001). Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacology & Therapeutics, 90, 157\u2013177. \nhttps:\/\/doi.org\/10.1016\/S0163-7258(01)00137-1","journal-title":"Pharmacology & Therapeutics"},{"key":"23_CR132","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1210\/en.2007-1173","volume":"149","author":"P Galluzzo","year":"2008","unstructured":"Galluzzo, P., Ascenzi, P., Bulzomi, P., & Marino, M. (2008). The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation. Endocrinology, 149, 2567\u20132575. \nhttps:\/\/doi.org\/10.1210\/en.2007-1173","journal-title":"Endocrinology"},{"key":"23_CR133","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s12035-014-9042-9","volume":"53","author":"LH Wu","year":"2016","unstructured":"Wu, L. H., Lin, C., Lin, H. Y., et al. (2016). Naringenin suppresses neuroinflammatory responses through inducing suppressor of cytokine signaling 3 expression. Molecular Neurobiology, 53, 1080\u20131091. \nhttps:\/\/doi.org\/10.1007\/s12035-014-9042-9","journal-title":"Molecular Neurobiology"},{"key":"23_CR134","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2012.10.041","volume":"230","author":"SS Raza","year":"2013","unstructured":"Raza, S. S., Khan, M. M., Ahmad, A., et al. (2013). Neuroprotective effect of naringenin is mediated through suppression of NF-\u03baB signaling pathway in experimental stroke. Neuroscience, 230, 157\u2013171. \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2012.10.041","journal-title":"Neuroscience"},{"key":"23_CR135","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jff.2018.05.065","volume":"47","author":"R Bhandari","year":"2018","unstructured":"Bhandari, R., Paliwal, J. K., & Kuhad, A. (2018). Naringenin and its nanocarriers as potential phytotherapy for autism spectrum disorders. Journal of Functional Foods, 47, 361\u2013375. \nhttps:\/\/doi.org\/10.1016\/j.jff.2018.05.065","journal-title":"Journal of Functional Foods"},{"key":"23_CR136","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.etp.2010.11.005","volume":"64","author":"CE Guerrero-Beltr\u00e1n","year":"2012","unstructured":"Guerrero-Beltr\u00e1n, C. E., Calder\u00f3n-Oliver, M., Pedraza-Chaverri, J., & Chirino, Y. I. (2012). Protective effect of sulforaphane against oxidative stress: Recent advances. Experimental and Toxicologic Pathology, 64, 503\u2013508. \nhttps:\/\/doi.org\/10.1016\/j.etp.2010.11.005","journal-title":"Experimental and Toxicologic Pathology"},{"key":"23_CR137","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.freeradbiomed.2013.08.182","volume":"65","author":"M Negrette-Guzm\u00e1n","year":"2013","unstructured":"Negrette-Guzm\u00e1n, M., Huerta-Yepez, S., Tapia, E., & Pedraza-Chaverri, J. (2013). Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: A seemingly contradictory dual role and an integrative hypothesis. Free Radical Biology & Medicine, 65, 1078\u20131089. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.08.182","journal-title":"Free Radical Biology & Medicine"},{"key":"23_CR138","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/jnr.22307","volume":"88","author":"L Soane","year":"2010","unstructured":"Soane, L., Li Dai, W., Fiskum, G., & Bambrick, L. L. (2010). Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation. Journal of Neuroscience Research, 88, 1355\u20131363. \nhttps:\/\/doi.org\/10.1002\/jnr.22307","journal-title":"Journal of Neuroscience Research"},{"key":"23_CR139","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1159\/000447799","volume":"39","author":"G Wang","year":"2016","unstructured":"Wang, G., Fang, H., Zhen, Y., et al. (2016). Sulforaphane prevents neuronal apoptosis and memory impairment in diabetic rats. Cellular Physiology and Biochemistry, 39, 901\u2013907. \nhttps:\/\/doi.org\/10.1159\/000447799","journal-title":"Cellular Physiology and Biochemistry"},{"key":"23_CR140","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1073\/pnas.91.8.3147","volume":"91","author":"Y Zhang","year":"1994","unstructured":"Zhang, Y., Kensler, T. W., Cho, C. G., et al. (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proceedings of the National Academy of Sciences, 91, 3147\u20133150. \nhttps:\/\/doi.org\/10.1073\/pnas.91.8.3147","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"23_CR141","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neulet.2005.09.065","volume":"393","author":"J Zhao","year":"2006","unstructured":"Zhao, J., Kobori, N., Aronowski, J., & Dash, P. K. (2006). Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neuroscience Letters, 393, 108\u2013112. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2005.09.065","journal-title":"Neuroscience Letters"},{"key":"23_CR142","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1523\/JNEUROSCI.3817-03.2004","volume":"24","author":"AD Kraft","year":"2004","unstructured":"Kraft, A. D., Johnson, D. A., & Johnson, J. A. (2004). Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. The Journal of Neuroscience, 24, 1101\u20131112. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.3817-03.2004","journal-title":"The Journal of Neuroscience"},{"key":"23_CR143","doi-asserted-by":"publisher","first-page":"35528","DOI":"10.1074\/jbc.M110.152686","volume":"285","author":"N Gan","year":"2010","unstructured":"Gan, N., Wu, Y. C., Brunet, M., et al. (2010). Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27. The Journal of Biological Chemistry, 285, 35528\u201335536. \nhttps:\/\/doi.org\/10.1074\/jbc.M110.152686","journal-title":"The Journal of Biological Chemistry"},{"key":"23_CR144","doi-asserted-by":"publisher","first-page":"15550","DOI":"10.1073\/pnas.1416940111","volume":"111","author":"K Singh","year":"2014","unstructured":"Singh, K., Connors, S. L., Macklin, E. A., et al. (2014). Sulforaphane treatment of autism spectrum disorder (ASD). Proceedings of the National Academy of Sciences, 111, 15550\u201315555. \nhttps:\/\/doi.org\/10.1073\/pnas.1416940111","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"23_CR145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13229-018-0218-4","volume":"9","author":"S Bent","year":"2018","unstructured":"Bent, S., Lawton, B., Warren, T., et al. (2018). Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli. Molecular Autism, 9, 35. \nhttps:\/\/doi.org\/10.1186\/s13229-018-0218-4","journal-title":"Molecular Autism"},{"key":"23_CR146","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ijms11041321","volume":"11","author":"M D\u2019Archivio","year":"2010","unstructured":"D\u2019Archivio, M., Filesi, C., Var\u00ec, R., et al. (2010). Bioavailability of the polyphenols: Status and controversies. International Journal of Molecular Sciences, 11, 1321\u20131342. \nhttps:\/\/doi.org\/10.3390\/ijms11041321","journal-title":"International Journal of Molecular Sciences"},{"key":"23_CR147","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/s41598-017-01888-w","volume":"7","author":"SNB Selby-Pham","year":"2017","unstructured":"Selby-Pham, S. N. B., Miller, R. B., Howell, K., et al. (2017). Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine. Scientific Reports, 7, 1931. \nhttps:\/\/doi.org\/10.1038\/s41598-017-01888-w","journal-title":"Scientific Reports"},{"key":"23_CR148","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/2230-973X.82432","volume":"1","author":"A Jithan","year":"2011","unstructured":"Jithan, A., Madhavi, K., Madhavi, M., & Prabhakar, K. (2011). Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. International Journal of Pharmaceutical Investigation, 1, 119\u2013125. \nhttps:\/\/doi.org\/10.4103\/2230-973X.82432","journal-title":"International Journal of Pharmaceutical Investigation"},{"key":"23_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032616","volume":"7","author":"A Mathew","year":"2012","unstructured":"Mathew, A., Fukuda, T., Nagaoka, Y., et al. (2012). Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One, 7, e32616. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0032616","journal-title":"PLoS One"},{"key":"23_CR150","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1477-3155-10-38","volume":"10","author":"AP Ranjan","year":"2012","unstructured":"Ranjan, A. P., Mukerjee, A., Helson, L., & Vishwanatha, J. K. (2012). Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. Journal of Nanobiotechnology, 10, 38. \nhttps:\/\/doi.org\/10.1186\/1477-3155-10-38","journal-title":"Journal of Nanobiotechnology"},{"key":"23_CR151","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1021\/jf202135j","volume":"59","author":"X Xie","year":"2011","unstructured":"Xie, X., Tao, Q., Zou, Y., et al. (2011). PLGA nanoparticles improve the oral bioavailability of Curcumin in rats: Characterizations and mechanisms. Journal of Agricultural and Food Chemistry, 59, 9280\u20139289. \nhttps:\/\/doi.org\/10.1021\/jf202135j","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"23_CR152","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1517\/17425247.2014.890588","volume":"11","author":"G Singh","year":"2014","unstructured":"Singh, G., & Pai, R. S. (2014). Optimized PLGA nanoparticle platform for orally dosed trans -resveratrol with enhanced bioavailability potential. Expert Opinion on Drug Delivery, 11, 647\u2013659. \nhttps:\/\/doi.org\/10.1517\/17425247.2014.890588","journal-title":"Expert Opinion on Drug Delivery"},{"key":"23_CR153","doi-asserted-by":"publisher","first-page":"e18033","DOI":"10.1371\/journal.pone.0018033","volume":"6","author":"M Shulman","year":"2011","unstructured":"Shulman, M., Cohen, M., Soto-Gutierrez, A., et al. (2011). Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-\u03b2-cyclodextrin. PLoS One, 6, e18033. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0018033","journal-title":"PLoS One"},{"key":"23_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0131026","volume":"10","author":"MJ Tsai","year":"2015","unstructured":"Tsai, M. J., Huang, Y. B., Fang, J. W., et al. (2015). Preparation and characterization of naringenin-loaded elastic liposomes for topical application. PLoS One, 10, 1\u201312. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0131026","journal-title":"PLoS One"},{"key":"23_CR155","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1208\/s12249-016-0537-8","volume":"18","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Wang, S., Firempong, C. K., et al. (2017). Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: Preparation and in vitro and in vivo evaluations. AAPS PharmSciTech, 18, 586\u2013594. \nhttps:\/\/doi.org\/10.1208\/s12249-016-0537-8","journal-title":"AAPS PharmSciTech"},{"key":"23_CR156","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.carbpol.2013.07.010","volume":"98","author":"L-J Yang","year":"2013","unstructured":"Yang, L.-J., Ma, S.-X., Zhou, S.-Y., et al. (2013). Preparation and characterization of inclusion complexes of naringenin with \u03b2-cyclodextrin or its derivative. Carbohydrate Polymers, 98, 861\u2013869. \nhttps:\/\/doi.org\/10.1016\/j.carbpol.2013.07.010","journal-title":"Carbohydrate Polymers"},{"issue":"4","key":"23_CR157","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11095-008-9791-0","volume":"26","author":"F-L Yen","year":"2008","unstructured":"Yen, F.-L., Wu, T.-H., Lin, L.-T., et al. (2008). Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl 4 -induced acute liver failure. Pharmaceutical Research, 26(4), 893\u2013902. \nhttps:\/\/doi.org\/10.1007\/s11095-008-9791-0","journal-title":"Pharmaceutical Research"},{"key":"23_CR158","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11095-008-9791-0","volume":"26","author":"F-L Yen","year":"2009","unstructured":"Yen, F.-L., Wu, T.-H., Lin, L.-T., et al. (2009). Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharmaceutical Research, 26, 893\u2013902. \nhttps:\/\/doi.org\/10.1007\/s11095-008-9791-0","journal-title":"Pharmaceutical Research"},{"issue":"5","key":"23_CR159","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3109\/10837450.2016.1146296","volume":"22","author":"H Danafar","year":"2017","unstructured":"Danafar, H., Sharafi, A., Manjili, H. K., & Andalib, S. (2017). Sulforaphane delivery using mPEG\u2013PCL co-polymer nanoparticles to breast cancer cells. Pharmaceutical Development and Technology, 22(5), 642\u2013651. \nhttps:\/\/doi.org\/10.3109\/10837450.2016.1146296","journal-title":"Pharmaceutical Development and Technology"},{"key":"23_CR160","unstructured":"Demio, P. C., & Finley-Belgrad, E. (2011). A clinical study of effects of Enhansa\u00ae (enhanced absorption curcumin) on immunologic and cognitive\/metabolic disorders\u00a0\u2013 An overview of results."},{"key":"23_CR161","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nature05488","volume":"79","author":"C Manach","year":"2004","unstructured":"Manach, C., Scalbert, A., Morand, C., et al. (2004). Bioavailability, polyphenols: Food sources and. The American Journal of Clinical Nutrition, 79, 727\u2013747. \nhttps:\/\/doi.org\/10.1038\/nature05488","journal-title":"The American Journal of Clinical Nutrition"},{"key":"23_CR162","doi-asserted-by":"publisher","unstructured":"Teng, H., & Chen, L. (2018). Polyphenols and bioavailability: An update. Critical Reviews in Food Science and Nutrition, 00\u201300. \nhttps:\/\/doi.org\/10.1080\/10408398.2018.1437023","DOI":"10.1080\/10408398.2018.1437023"},{"key":"23_CR163","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.3390\/nu5093367","volume":"5","author":"SH Thilakarathna","year":"2013","unstructured":"Thilakarathna, S. H., & Vasantha Rupasinghe, H. P. (2013). Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients, 5, 3367\u20133387. \nhttps:\/\/doi.org\/10.3390\/nu5093367","journal-title":"Nutrients"},{"key":"23_CR164","doi-asserted-by":"crossref","unstructured":"Pardridge, W. M. (2001). Brain drug targeting: The future of brain drug development. Cambridge University Press.","DOI":"10.1017\/CBO9780511549571"},{"key":"23_CR165","doi-asserted-by":"publisher","first-page":"82","DOI":"10.7326\/0003-4819-105-1-82","volume":"105","author":"WM Pardridge","year":"1986","unstructured":"Pardridge, W. M., Oldendorf, W. H., Cancilla, P., & Frank, H. J. (1986). Blood-brain barrier: Interface between internal medicine and the brain. Annals of Internal Medicine, 105, 82\u201395.","journal-title":"Annals of Internal Medicine"},{"key":"23_CR166","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1358\/dot.2004.40.1.799434","volume":"40","author":"JH Lin","year":"2004","unstructured":"Lin, J. H. (2004). How significant is the role of P-glycoprotein in drug absorption and brain uptake? Drugs Today (Barc), 40, 5\u201322.","journal-title":"Drugs Today (Barc)"},{"key":"23_CR167","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher, W., & Potschka, H. (2005). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx, 2, 86\u201398. \nhttps:\/\/doi.org\/10.1602\/neurorx.2.1.86","journal-title":"NeuroRx"}],"container-title":["Advances in Neurobiology","Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-30402-7_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T09:50:14Z","timestamp":1580723414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-30402-7_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030304010","9783030304027"],"references-count":167,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-30402-7_23","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"1 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}